Dynavax Technologies Corporation (DVAX)
-NasdaqCM | Prev Close: | 1.04 |
|---|
| Open: | N/A |
|---|
| Bid: | 1.01 x 1000 |
|---|
| Ask: | 1.19 x 3000 |
|---|
| 1y Target Est: | 3.58 |
|---|
| Beta: | 3.22 |
|---|
| Next Earnings Date: | 29-Jul-13 |
|---|
| Day's Range: | N/A - N/A |
|---|
| 52wk Range: | 0.99 - 5.10 |
|---|
| Volume: | 0 |
|---|
| Avg Vol (3m): | 2,647,890 |
|---|
| Market Cap: | 190.21M |
|---|
| P/E (ttm): | N/A |
|---|
| EPS (ttm): | -0.42 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- Robbins Geller Rudman & Dowd LLP Files Class Action Suit against Dynavax Technologies CorporationBusiness Wire(Tue, Jun 18)
- SHAREHOLDER ALERT: Brower Piven Announces an Investigation of Dynavax Technologies Corporation for Potential Violations of the Federal Securities LawsBusiness Wire(Tue, Jun 18)
- This Week in Biotechat Motley Fool(Sat, Jun 15)
- The Best- And Worst-Performing Biotech Stocks June 7 To June 14at Forbes(Sat, Jun 15)
- 3 Horrendous Health-Care Stocks This Weekat Motley Fool(Fri, Jun 14)
- Investor Alert: Holzer Holzer & Fistel, LLC Announces Investigation into Dynavax Technologies CorporationBusiness Wire(Thu, Jun 13)
- Law Firm Finkelstein Thompson LLP Announces Investigation of Dynavax Technologies Corp.Business Wire(Wed, Jun 12)
- Dynavax Down on Heplisav DelayZacks(Tue, Jun 11)
- Law Offices of Howard G. Smith Announces Investigation On Behalf of Shareholders of Dynavax Technologies CorporationBusiness Wire(Tue, Jun 11)
- Dynavax Technologies - DVAX And Nothing But DVAXat Seeking Alpha(Tue, Jun 11)
- Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Dynavax Technologies CorporationPR Newswire(Tue, Jun 11)
- Dynavax to Present at the William Blair 33rd Annual Growth Stock ConferenceMarketwired(Tue, Jun 11)
- Why Dynavax Technologies Shares Were Evisceratedat Motley Fool(Mon, Jun 10)
- Dynavax Technologies Corporation - Special Callat Seeking Alpha(Mon, Jun 10)
- DVAX, RDY, ONXX, ALXN And VRX, 5 Health Care Stocks Pushing The Sector Lowerat TheStreet(Mon, Jun 10)
Comparison
| Symbol | % Chg | Mkt Cap |
|---|
| DVAX | 0.00% | 190.21M |
| NVO | 0.00% | 87.67B |
| TEVA | 0.00% | 33.77B |
| AGN | 0.00% | 30.08B |
| FRX | 0.00% | 11.09B |
Key Statistics
| Forward P/E (1 yr): | N/A |
|---|
| P/S (ttm): | 20.13 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | -0.39 |
|---|
| Quarterly EPS Est
(Jun-13)
: | -0.10 |
|---|
| Mean Recommendation*: | 2.2 |
|---|
| PEG Ratio (5 yr expected): | N/A |
|---|
Business Summary
Dynavax Technologies Corporation, a clinical-stage biopharmaceutical company, discovers and develops novel products to prevent and treat infectious and inflammatory diseases.
View More